Jens Würthner

Jens has 20+ years of clinical development experience from research institutions as well as big pharma and biotech companies including Novartis, GlaxoSmithKline, AstraZeneca, and most recently ADC Therapeutics. Jens joined Scenic in 2022 as Chief Medical Officer.


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Scenic Biotech

1 followers

Scenic Biotech is applying a novel approach to target discovery by harnessing genetic suppressors


Industries

Employees

11-50

Links